You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 9, September 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Normothermic Rapid Volume Replacement in Traumatic Hypovolemia

A Prospective Analysis Using a New Device

Bhagwan Satiani, MB, BS; Steven J. Fried, CT; Paul Zeeb, MD; Robert E. Falcone, MD

Arch Surg. 1987;122(9):1044-1047.


Abstract

• Inadequate infusion flow rates and hypothermia are significant problems encountered in managing traumatic hemorrhagic shock. The Rapid Solution Administration Set (RSAS) allows normothermic volume restoration at flow rates of up to 2200 mL/min via a single peripheral venipuncture. The RSAS was utilized in 33 consecutive multiple-trauma patients with a mean trauma score (TS) of 6.8. Admission systolic blood pressure averaged 66.9 mm Hg. A mean of 5692 mL of packed red blood cells, 5515 mL of blood products, and 12 052 mL of crystalloid solution per patient was infused within 24 hours of admission mostly via the RSAS. Mortality was 45% at 24 hours following arrival and 61% overall. The mortality was 93.8% (15/16) in patients with a TS of 5 or less and 29.4% (5/17) in patients with a TS over 5. The initial postinfusion patient temperatures averaged 35.2°C. All abnormal preinfusion coagulation values normalized within 24 hours in the survivors, and no significant complications occurred with the use of the RSAS. The RSAS seems to provide an uncomplicated means of normothermic volume replacement. The 24-hour survival in potentially salvageable patients may be improved. Its use In patients with lethal injuries (TS <3) requires further evaluation.

(Arch Surg 1987;122:1044-1047)



Author Affiliations

From the Departments of Surgery (Drs Satiani and Falcone), Cardiovascular Services (Mr Fried), and Emergency Medicine (Dr Zeeb), Grant Medical Center, Columbus, Ohio.


Footnotes

Accepted for publication July 31, 1986.

Reprint requests to Grant Medical Center, 300 E Town St, Columbus, OH 43215 (Dr Satiani).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rapid Transfusion Devices for Hemorrhagic Cardiothoracic Trauma
Elia and Kang
SEMIN CARDIOTHORAC VASC ANESTH 2002;6:105-112.
ABSTRACT  

Rapid Volume Replacement With Warmed Blood and Fluids
Falcone et al.
ANGIOLOGY 1989;40:964-969.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.